Cargando…
The Lung Microbiome: A Central Mediator of Host Inflammation and Metabolism in Lung Cancer Patients?
SIMPLE SUMMARY: Lung cancer is the major cause of cancer related deaths in the world. New therapies have improved outcomes. Unfortunately, overall 5 year survival is ~20%. Therefore, better understanding of tumor biology and the microenvironment may lead to new therapeutic targets. The lung microbio...
Autores principales: | Weinberg, Frank, Dickson, Robert P., Nagrath, Deepak, Ramnath, Nithya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792810/ https://www.ncbi.nlm.nih.gov/pubmed/33375062 http://dx.doi.org/10.3390/cancers13010013 |
Ejemplares similares
-
Reactive Oxygen Species in the Tumor Microenvironment: An Overview
por: Weinberg, Frank, et al.
Publicado: (2019) -
Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions
por: Zhang, Zhuo, et al.
Publicado: (2015) -
Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches
por: Sankar, Kamya, et al.
Publicado: (2021) -
Optimizing the Detection of Circulating Markers to Aid in Early Lung Cancer Detection
por: Murlidhar, Vasudha, et al.
Publicado: (2016) -
Characterization of pneumonia and other factors leading to poorer survival across all age groups in patients with non-small cell lung cancer (NSCLC)
por: Weinberg, Frank D., et al.
Publicado: (2021)